Oda Yutaka, Funao Tomoharu, Tanaka Katsuaki, Asada Akira
Department of Anesthesiology and Intensive Care Medicine, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Anesth Analg. 2004 Mar;98(3):677-82, table of contents. doi: 10.1213/01.ane.0000101984.50597.e9.
Bupivacaine affects the vascular resistance by peripheral and central nervous system (CNS) mechanisms. As vasoconstrictors increase the CNS toxicity of IV bupivacaine, vasodilators may decrease its CNS toxicity. We examined the hypothesis that vasodilators decrease the CNS toxicity of bupivacaine in awake, spontaneously breathing rats. Male Sprague-Dawley rats were randomly divided into control (C), nicardipine (N), and phentolamine (P) groups (n = 12 in each group). Racemic bupivacaine was administered IV at 1 mg/kg/min until tonic/clonic convulsions occurred. Saline, nicardipine (0.4 microg/min), and phentolamine (10 microg/min within 5 min, 50 microg/min thereafter) were simultaneously administered with bupivacaine in groups C, N, and P, respectively. Mean arterial blood pressure was significantly increased by infusion of bupivacaine in group C and was maintained at baseline levels before the onset of convulsions in groups N and P. The convulsive dose of bupivacaine in group C was 5.8 +/- 1.5 mg/kg, but was significantly larger in groups N and P (7.6 +/- 1.5 and 8.1 +/- 1.1 mg/kg, P = 0.02 and 0.001, respectively). However, there were no differences in total or protein-unbound plasma concentration of bupivacaine or in concentration of bupivacaine in the brain at the onset of convulsions among the 3 groups. We conclude that nicardipine and phentolamine increase the cumulative dose but do not affect the threshold plasma or brain concentrations required for bupivacaine-induced convulsions.
Bupivacaine, a long-acting local anesthetic, induces central nervous system toxicity when its plasma concentration is increased. Nicardipine and phentolamine increased the cumulative dose but did not affect the threshold plasma concentrations, required for bupivacaine-induced convulsions, suggesting that both nicardipine and phentolamine inhibited the increase in the plasma concentration of bupivacaine by inducing peripheral vasodilation.
布比卡因通过外周和中枢神经系统(CNS)机制影响血管阻力。由于血管收缩剂会增加静脉注射布比卡因的中枢神经系统毒性,血管扩张剂可能会降低其中枢神经系统毒性。我们检验了血管扩张剂可降低清醒、自主呼吸大鼠布比卡因中枢神经系统毒性的假说。将雄性Sprague-Dawley大鼠随机分为对照组(C)、尼卡地平组(N)和酚妥拉明组(P)(每组n = 12)。消旋布比卡因以1 mg/kg/min的速度静脉给药,直至出现强直性/阵挛性惊厥。分别在C、N和P组中,生理盐水、尼卡地平(0.4 μg/min)和酚妥拉明(5分钟内10 μg/min,此后50 μg/min)与布比卡因同时给药。C组中输注布比卡因可显著提高平均动脉血压,而N组和P组在惊厥发作前平均动脉血压维持在基线水平。C组布比卡因的惊厥剂量为5.8±1.5 mg/kg,但在N组和P组中显著更高(分别为7.6±1.5和8.1±1.1 mg/kg,P分别为0.02和0.001)。然而,三组惊厥发作时布比卡因的总血浆浓度或蛋白结合血浆浓度以及脑中布比卡因浓度均无差异。我们得出结论,尼卡地平和酚妥拉明增加了累积剂量,但不影响布比卡因诱导惊厥所需的血浆或脑浓度阈值。
布比卡因是一种长效局部麻醉剂,当血浆浓度升高时会诱发中枢神经系统毒性。尼卡地平和酚妥拉明增加了累积剂量,但不影响布比卡因诱导惊厥所需的血浆浓度阈值,这表明尼卡地平和酚妥拉明均通过诱导外周血管扩张抑制了布比卡因血浆浓度的升高。